WTKWY
Get informed when a big investor buys or sells
+ FollowJuly 31, 2024 - AI Summary
Undervalued by 184.5% based on the discounted cash flow analysis.
| Market cap | $15.91 Billion |
|---|---|
| Enterprise Value | $22.10 Billion |
| Dividend Yield | $2.97 (4.12%) |
| Earnings per Share | $5.44 |
| Beta | 0.15 |
| Outstanding Shares | 226,198,000 |
| P/E Ratio | 10.57 |
|---|---|
| PEG | 33.57 |
| Price to Sales | 1.33 |
| Price to Book Ratio | 23.48 |
| Enterprise Value to Revenue | 1.84 |
| Enterprise Value to EBIT | 7.43 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 8.93 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Assists tax-writing committees and provides official revenue estimates. Its work directly shapes the tax landscape, which is fundamental to Wolters Kluwer's core Tax & Accounting software and services, making insider information extremely valuable.
Controls taxation and trade. This committee directly impacts Wolters Kluwer's massive Tax & Accounting segment through tax policy changes, which drive demand for their software and services. It also influences healthcare funding.
Regulates the FDA, NIH, and labor laws. This directly impacts Wolters Kluwer's healthcare solutions (e.g., drug approval content) and their payroll/HR services through labor regulations.
Oversees intellectual property and antitrust laws. Intellectual property protection is critical for Wolters Kluwer's information and software business model, and antitrust actions can impact M&A strategies or competitive landscape.
Directly regulates the financial system (Fed, SEC, HUD). Wolters Kluwer provides extensive compliance, risk management, and regulatory reporting solutions for financial institutions, making this committee's actions profoundly impactful.